Evidence map›Paper›PMID 31342059›Full record

SynthesisAdvances in nutrition (Bethesda, Md.)2020

The Effect of Isolated and Synthetic Dietary Fibers on Markers of Metabolic Diseases in Human Intervention Studies: A Systematic Review.

Anissa M Armet, Edward C Deehan, Julia V Thöne, Sarah J Hewko, Jens Walter

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Advances in nutrition (Bethesda, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06416254 (The Effects of a Diet Enriched With Dietary Fibre on Glycaemic Response, Gastrointestinal Tolerability, Satiety, and Microbiome Functionality), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06416254 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effects of a Diet Enriched With Dietary Fibre on Glycaemic Response, Gastrointestinal Tolerability, Satiety, and Microbiome Functionality (The Fibre Full Study).

TypeinterventionalSponsorUniversity College CorkRan2024 to 2024Enrolled24ConditionsOverweight and ObesityArmsFibre-enriched diet, Control diet
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Dietary fibre and metabolic health: A clinical primer.Clinical and translational medicine · 2024
    Article
  15. The Consumption of the Fibrous Fraction ofFoods (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anissa M ArmetDepartment of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
Edward C DeehanDepartment of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
Julia V ThöneDepartment of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
Sarah J HewkoDepartment of Applied Human Sciences, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.
Jens WalterDepartment of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CAUniversity of Prince Edward Island · CA

Funding

CIHR
6 · The paper itself

Abstract

Observational studies provide strong evidence for the health benefits of dietary fiber (DF) intake; however, human intervention studies that supplement isolated and synthetic DFs have shown inconsistent results. Therefore, we conducted a systematic review to summarize the effects of DF supplementation on immunometabolic disease markers in intervention studies in healthy adults, and considered the role of DF dose, DF physicochemical properties, intervention duration, and the placebo used. Five databases were searched for studies published from 1990 to 2018 that assessed the effect of DF on immunometabolic markers. Eligible studies were those that supplemented isolated or synthetic DFs for ≥2 wk and reported baseline data to assess the effect of the placebo. In total, 77 publications were included. DF supplementation reduced total cholesterol (TC), LDL cholesterol, HOMA-IR, and insulin AUC in 36-49% of interventions. In contrast, <20% of the interventions reduced C-reactive protein (CRP), IL-6, glucose, glucose AUC, insulin, HDL cholesterol, and triglycerides. A higher proportion of interventions showed an effect if they used higher DF doses for CRP, TC, and LDL cholesterol (40-63%), viscous and mixed plant cell wall DFs for TC and LDL cholesterol (>50%), and longer intervention durations for CRP and glucose (50%). Half of the placebo-controlled studies used digestible carbohydrates as the placebo, which confounded findings for IL-6, glucose AUC, and insulin AUC. In conclusion, interventions with isolated and synthetic DFs resulted mainly in improved cholesterol concentrations and an attenuation of insulin resistance, whereas markers of dysglycemia and inflammation were largely unaffected. Although more research is needed to make reliable recommendations, a more targeted supplementation of DF with specific physicochemical properties at higher doses and for longer durations shows promise in enhancing several of its health effects.

Indexed as

BiomarkersBlood GlucoseCholesterolClinical Trials as TopicC-Reactive ProteinDietary FiberDietary SupplementsHumansInsulinInsulin ResistanceLipidsMetabolic DiseasesPilot ProjectsPlacebosBiomarkersBlood GlucoseCholesterolC-Reactive ProteinDietary FiberInsulinLipidsPlacebosadultsdietary fiberdysglycemiadyslipidemiainsulin resistancesystemic inflammation

Identifiers

PMID31342059
PMCPMC7442353
OpenAlexW2963632228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.